BYETTA is a non-insulin type 2 diabetes injection medication for adults. Important Safety Information for BYETTA (exenatide) injection . with prior severe hypersensitivity reactions to exenatide or to any of the product components. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution for injection in pre-filled pen exenatide. Read all of this leaflet carefully.
|Published (Last):||26 January 2005|
|PDF File Size:||18.51 Mb|
|ePub File Size:||7.96 Mb|
|Price:||Free* [*Free Regsitration Required]|
Postmarketing reports of altered renal function, including increased serum creatinine, renal impairment, worsened chronic renal failure, and acute renal failure, sometimes requiring hemodialysis and kidney transplantation.
After initiation and dose increases of BYETTA, observe patients carefully for pancreatitis including persistent severe abdominal pain, sometimes radiating to the back, with or without vomiting.
Approved Uses BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise. Stop taking BYETTA and call your healthcare provider right away if you have pain in your stomach area abdomen that is severe, and will not go away, occurs packaage or without vomiting or is felt going from your abdomen through to your back.
Welcome to BYETTA.com!
All other trademarks are property of their respective owners. imsert
Signs and symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, and feeling jittery. The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, inwert, headache, acid stomach, constipation, and weakness. The Double B logo is a trademark of the AstraZeneca group of companies.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
Should not be used in patients with severe renal impairment or end-stage renal disease. When used with insulin, evaluate and consider reducing the insulin dose in patients at increased risk of hypoglycemia. Postmarketing reports of increased international normalized ratio INR sometimes associated with bleeding with concomitant use of warfarin.
To report drug exposure during pregnancy call Use with caution in patients with renal transplantation or when initiating or escalating the indert in patients with moderate renal failure. You may give other people a serious infection, or get a serious infection from them. Inflammation of the pancreas pancreatitis may happen, which exenayide be severe and lead to death.
Official BYETTA® (exenatide) injection Healthcare Professional Website
No placebo-treated patients withdrew due to nausea or vomiting. Pen-sharing poses a risk for transmission of blood-borne pathogens, even if the needle is changed.
Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. Go to Patient Site. Before taking BYETTA, tell your healthcare provider if you have had pancreatitis, stones in your gallbladder gallstonesa history of alcoholism, or high blood triglyceride levels.
Oral medications dependent on threshold concentrations for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA. Use with caution with medications that have a narrow therapeutic index or require rapid gastrointestinal absorption. No clinical studies establishing conclusive evidence of macrovascular risk reduction with BYETTA or any other antidiabetic drug. Use of twice-daily exenatide in basal insulin—treated patients with type 2 diabetes: BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
Type 2 Diabetes Medication | BYETTA® (exenatide) injection
This site is intended for US Consumers. BYETTA should not be used in people exehatide type 1 diabetes exenatjde people with diabetic ketoacidosis a condition caused by very high blood sugar. Patients may develop antibodies to exenatide. Talk to your healthcare provider first if you are breastfeeding or plan to breastfeed.
The most frequently reported adverse reactions leading to withdrawal for Byetta-treated patients were nausea 5. Drug Interactions Oral Medications: Concurrent use with prandial insulin has not been studied and cannot be recommended.
Staying Active Learn how regular physical activity can help you manage type 2 diabetes. Postmarketing apckage of serious hypersensitivity reactions eg anaphylaxis and angioedema. You are encouraged to report negative side effects of prescription drugs to the FDA.
The site you are about to visit xeenatide maintained by a third party who is solely responsible for its contents. All other trademarks are property of their respective owners. Tell your healthcare provider if you have or had kidney problems or a kidney transplant. Based on animal data, BYETTA may cause fetal harm and should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Go to Healthcare Professional Site. Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that pafkage not go away, or if you cannot take liquids by mouth. Not a substitute for insulin and should not be used in patients with type 1 diabetes or diabetic insret.
If worsening of or failure to achieve adequate glycemic control occurs, consider alternative antidiabetic therapy.